| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/02/2004 | EP1373562A2 Method for determining whether a test compound binds to a large rna target |
| 01/02/2004 | EP1373560A1 Oligonucleotide primers for the phosphatidylinositol specific phospholipase c gene and method for the detection of bacillus cereus |
| 01/02/2004 | EP1373559A2 Identification of neural defects associated with the nucleosomal assembly protein 1l2 gene |
| 01/02/2004 | EP1373557A2 Use of generic oligonucleotide microchips to detect protein-nucleic acid interactions |
| 01/02/2004 | EP1373555A2 Plasma phospholipid transfer protein (pltp) deficiency represents an anti-atherogenic state and pltp inhibitor has anti-atherosclerosis action |
| 01/02/2004 | EP1373554A2 Modulators of bruton's tyronsine kinase, their identification and use |
| 01/02/2004 | EP1373551A2 Multiple determinants for metabolic phenotypes |
| 01/02/2004 | EP1373550A1 Method of preparing supported lipid film membranes and use thereof |
| 01/02/2004 | EP1373545A2 Mch1r deficient mice |
| 01/02/2004 | EP1373529A1 Tau-opathy model |
| 01/02/2004 | EP1373525A1 Gene-targeted animal model of apolipoprotein e4 domain interaction and uses thereof |
| 01/02/2004 | EP1373518A2 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preparation of a medicament for the treatment of metabolic disorders |
| 01/02/2004 | EP1373517A2 Human kinases |
| 01/02/2004 | EP1373516A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
| 01/02/2004 | EP1373514A2 Phosphorylation modifications of apoptin |
| 01/02/2004 | EP1373511A2 Genes and proteins, and their uses |
| 01/02/2004 | EP1373510A2 Mutant allergens |
| 01/02/2004 | EP1373509A2 Desoxyribonucleic acids coding for the equine ige-allotype heavy chain constant region, the recombinant immunoglobulin obtained therewith and corresponding isotype-specific monoclonal antibodies and the utilization thereof |
| 01/02/2004 | EP1373508A2 Human cytokine receptor |
| 01/02/2004 | EP1373506A2 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter |
| 01/02/2004 | EP1373504A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 01/02/2004 | EP1373496A1 Methods for identifying peptides which modulate a biological process |
| 01/02/2004 | EP1373489A2 Human dual specificity protein phosphatase 7-like protein |
| 01/02/2004 | EP1373481A1 Methods of screening for introduction of dna into a target cell |
| 01/02/2004 | EP1373479A1 Methods for monitoring prothease inhibitor antiretroviral therapy |
| 01/02/2004 | EP1373477A2 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
| 01/02/2004 | EP1373472A1 Methods and gel compositions for encapsulating living cells and organic molecules |
| 01/02/2004 | EP1373470A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/02/2004 | EP1373467A1 Device and method for detection of multiple analytes |
| 01/02/2004 | EP1373320A2 Method for preparing and selecting antibodies |
| 01/02/2004 | EP1373318A2 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373309A2 Compositions and methods for identifying and distinguishing orthosomycin biosynthetic loci |
| 01/02/2004 | EP1373308A2 Multimerization of hiv-1 vif protein as a therapeutic target |
| 01/02/2004 | EP1373306A2 Cytoskeletion-associated proteins |
| 01/02/2004 | EP1373301A2 Reducing the immunogenicity of fusion proteins |
| 01/02/2004 | EP1373294A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 01/02/2004 | EP1373293A1 Steap-related protein |
| 01/02/2004 | EP1373246A2 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives |
| 01/02/2004 | EP1372850A2 Holding device, particularly for body fluids, comprising a separating device, and a separating device therefor |
| 01/02/2004 | EP1372848A1 Method and system for microfluidic interfacing to arrays |
| 01/02/2004 | EP1372841A2 Method for producing a plurality of identical copies of a two-dimensional test array of probe molecules |
| 01/02/2004 | EP1372828A2 Biochips including ion transport detecting structures and methods of use |
| 01/02/2004 | EP1372826A1 Method and device for assessing the operability of a device for reducing the ozone content in the air |
| 01/02/2004 | EP1372736A2 Anti-neovasculature preparations for cancer |
| 01/02/2004 | EP1372721A2 Method to screen peptide display libraries using minicell display |
| 01/02/2004 | EP1372718A2 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 01/02/2004 | EP1372716A2 Blood cell production via activation of the hemoglobin scavenger receptor (cd163) |
| 01/02/2004 | EP1372714A2 Method for inducing an immune response to polysaccharide bacterial antigens and to protein structures of virus capsids |
| 01/02/2004 | EP1372696A2 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 01/02/2004 | EP1372690A2 93870, a human g-protein coupled receptor and uses therefor |
| 01/02/2004 | EP1372689A2 Use of ikk-beta inhibitors and method for discovery of said inhibitors |
| 01/02/2004 | EP1372418A2 Non-oligomerizing tandem fluorescent proteins |
| 01/02/2004 | EP1058826B1 Random access slide stainer with liquid waste segregation |
| 01/02/2004 | EP1004015B1 Apparatus for performing assays at reaction sites |
| 01/02/2004 | EP0934428B1 Microbiological assessment method and device utilizing oxygen gradient sensing |
| 01/02/2004 | EP0858597B1 Transistor-based apparatus and method for molecular detection |
| 01/02/2004 | EP0772795B1 Switching device and the use thereof |
| 01/01/2004 | US20040003427 Novel basal endosperm transfer cell layer (BELT) specific genes |
| 01/01/2004 | US20040003425 Nav2 channel gene-deficient non-human animals |
| 01/01/2004 | US20040003422 An expression cassette containing the proopiomelanocortin (POMC) enhancer, and a nucleic acid sequence encoding POMC contains at least one exon, wherein a polylinker having an unique site for restriction enzyme is inserted into the exon; gene regulates weight and fat mass |
| 01/01/2004 | US20040003419 Novel taste receptors in Drosophila |
| 01/01/2004 | US20040003418 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer |
| 01/01/2004 | US20040002842 Methods and systems for analyzing complex biological systems |
| 01/01/2004 | US20040002818 Method, system and computer software for providing microarray probe data |
| 01/01/2004 | US20040002816 Positional hashing method for performing DNA sequence similarity search |
| 01/01/2004 | US20040002608 Central nervous system disorders |
| 01/01/2004 | US20040002595 Nucleic acid labeling compounds |
| 01/01/2004 | US20040002586 Crystal structure of interleukin-22 and uses thereof |
| 01/01/2004 | US20040002582 Miniprotein ligands and other polypeptides and methods for making and using same |
| 01/01/2004 | US20040002473 Pain modulation; incotinence therapy; central nervous system disorders |
| 01/01/2004 | US20040002459 Nucleic acids encoding kringle 1-5 region fragments of plasminogen |
| 01/01/2004 | US20040002447 Induction of insulin expression |
| 01/01/2004 | US20040002440 Modulation gene expression; binding antigen to polypeptide; therapy for infection |
| 01/01/2004 | US20040002169 Bioassay and biomolecular identification, sorting, and collection methods using magnetic microspheres |
| 01/01/2004 | US20040002167 Method and system for curve quality control |
| 01/01/2004 | US20040002161 Analytical test cartridge; and, methods |
| 01/01/2004 | US20040002160 Method and device for monitoring worker's exposure pattern at workplace |
| 01/01/2004 | US20040002154 Methods for preparing libraries of unique tags and related screening methods |
| 01/01/2004 | US20040002146 Enzyme-protein complex |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002128 Green fluorescent protein; activation by caspase or protease; determining change in the degree of fluorescence resonance energy transfer |
| 01/01/2004 | US20040002126 Method, device and system for detecting the presence of microorganisms |
| 01/01/2004 | US20040002125 Detection of abnormal cells |
| 01/01/2004 | US20040002124 Cyr61 compositions and methods |
| 01/01/2004 | US20040002123 Detection of transmembrane potentials by optical methods |
| 01/01/2004 | US20040002121 Collecting specimen and drying microplatform which contains a capture-moiety; extraction and detection; receptor-ligand assay |
| 01/01/2004 | US20040002119 Method of predicting cell-based assay results using binding profiles |
| 01/01/2004 | US20040002118 Treating with a digestion agent; spectrometry; use for identification and location within the amino acid sequence |
| 01/01/2004 | US20040002115 Method of identifying protein CAMs (constitutively active mutants) |
| 01/01/2004 | US20040002114 Nucleic acids encoding a G-protein coupled receptor involved in islet cell signaling |
| 01/01/2004 | US20040002113 Detection and treatment methods for type I diabetes |
| 01/01/2004 | US20040002111 Atherosclerosis vaccine |
| 01/01/2004 | US20040002110 Improved analyte-specific diffraction based diagnostic sensor to indicate the presence of the analyte in a medium |
| 01/01/2004 | US20040002109 Process for identifying modulators of G-protein-coupled receptors |
| 01/01/2004 | US20040002108 Predicting the significance of single nucleotide polymorphisms (SNPs) using ensemble-based structural energetics |
| 01/01/2004 | US20040002103 Synthetic ligation reassembly in directed evolution |